Working on projects across Uptake, Mary brings significant industry and consulting experience in commercial strategy, brand implementation, forecasting and launch excellence.
Mary has over 20 years’ experience in the pharmaceutical industry, including roles at Pfizer and Sanofi. Mary began her career in pharmacovigilance and medical information before moving into marketing, where she led brands in both the UK and the US.
Her deep expertise in Patient Advocacy includes partnering with global and US teams to articulate the impact, value and strategic importance of advocacy initiatives. She is skilled at translating advocacy outcomes into clear, compelling narratives that resonate with commercial stakeholders, demonstrating how advocacy supports brand objectives, market shaping and patient access.
Close collaboration with senior global leadership, R&D, and partner companies has seen her advise on pipeline strategy, strategic projects, integrated evidence‑generation planning, product launches and patent expiry management.
With extensive experience across commercial strategy, forecasting, new product development, launch excellence and marketed products spanning immunology, oncology, rare diseases, cardiovascular, CNS, anti-infectives, diabetes and ophthalmology, Mary brings a practical and solution-oriented focus to projects.
Mary describes herself as insightful, organized and creative.
